For: | Perboni S, Bowers C, Kojima S, Asakawa A, Inui A. Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluorouracil in colon cancer cell-bearing mice. World J Gastroenterol 2008; 14(41): 6303-6305 [PMID: 19009643 DOI: 10.3748/wjg.14.6303] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i41/6303.htm |
Number | Citing Articles |
1 |
Joshua Runtuwene, Haruka Amitani, Marie Amitani, Akihiro Asakawa, Kai-Chun Cheng, Akio Inui. Hydrogen–water enhances 5-fluorouracil-induced inhibition of colon cancer. PeerJ 2015; 3: e859 doi: 10.7717/peerj.859
|
2 |
Maria Hamze Sinno, Quentin Coquerel, Nabile Boukhettala, Moïse Coëffier, Syrine Gallas, Mutsumi Terashi, Ayman Ibrahim, Denis Breuillé, Pierre Déchelotte, Sergueï O. Fetissov. Chemotherapy-induced anorexia is accompanied by activation of brain pathways signaling dehydration. Physiology & Behavior 2010; 101(5): 639 doi: 10.1016/j.physbeh.2010.09.016
|
3 |
Johannes D. Veldhuis, Cyril Y. Bowers. Integrating GHS into the Ghrelin System. International Journal of Peptides 2010; 2010: 1 doi: 10.1155/2010/879503
|
4 |
Elena Bresciani, Laura Rizzi, Laura Molteni, Monica Ravelli, Antonella Liantonio, Khoubaib Ben Haj Salah, Jean-Alain Fehrentz, Jean Martinez, Robert J. Omeljaniuk, Giuseppe Biagini, Vittorio Locatelli, Antonio Torsello. JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia. Endocrine 2017; 58(1): 106 doi: 10.1007/s12020-016-1184-2
|
5 |
Yoshihiro Shiomi, Yuta Ohira, Makoto Yoshimura, Tomoko Ozaki, Mineo Takei, Takao Tanaka. Z-505 hydrochloride ameliorates chemotherapy-induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a. European Journal of Pharmacology 2018; 818: 148 doi: 10.1016/j.ejphar.2017.10.047
|
6 |
Aldona Kasprzak. Role of the Ghrelin System in Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(10): 5380 doi: 10.3390/ijms23105380
|
7 |
Claudio Pietra, Yasuhiro Takeda, Naoko Tazawa-Ogata, Masashi Minami, Xia Yuanfeng, Elizabeth Manning Duus, Robert Northrup. Anamorelin HCl (ONO‐7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia‐cachexia syndrome: preclinical profile. Journal of Cachexia, Sarcopenia and Muscle 2014; 5(4): 329 doi: 10.1007/s13539-014-0159-5
|
8 |
Osama N. Zamel, Ergie P. Inocian, Abdualrahman S. Alshehry, Regie B. Tumala, Joel G. Patalagsa, Khalid A. Alsaleh. Quality of Life Among Breast and Colon Cancer Patients Before and After First-Cycle Chemotherapy. Journal of Holistic Nursing 2021; 39(2): 116 doi: 10.1177/0898010120958859
|
9 |
Angela Esposito, Carmen Criscitiello, Lucia Gelao, Gabriella Pravettoni, Marzia Locatelli, Ida Minchella, Maria Di Leo, Rita Liuzzi, Alessandra Milani, Mariangela Massaro, Giuseppe Curigliano. Mechanisms of anorexia–cachexia syndrome and rational for treatment with selective ghrelin receptor agonist. Cancer Treatment Reviews 2015; 41(9): 793 doi: 10.1016/j.ctrv.2015.09.002
|
10 |
Sulaiman Sheriff, Rashika Joshi, Lou Ann Friend, J. Howard James, Ambikaipakan Balasubramaniam. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. Peptides 2009; 30(10): 1909 doi: 10.1016/j.peptides.2009.06.029
|
11 |
Jorge Berlanga-Acosta, Angel Abreu-Cruz, Diana García-del Barco Herrera, Yssel Mendoza-Marí, Arielis Rodríguez-Ulloa, Ariana García-Ojalvo, Viviana Falcón-Cama, Francisco Hernández-Bernal, Qu Beichen, Gerardo Guillén-Nieto. Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects. Clinical Medicine Insights: Cardiology 2017; 11: 117954681769455 doi: 10.1177/1179546817694558
|
12 |
Theodore P. Braun, Daniel L. Marks. Pathophysiology and treatment of inflammatory anorexia in chronic disease. Journal of Cachexia, Sarcopenia and Muscle 2010; 1(2): 135 doi: 10.1007/s13539-010-0015-1
|
13 |
Marie François, Kuniko Takagi, Romain Legrand, Nicolas Lucas, Stephanie Beutheu, Christine Bôle-Feysot, Aurore Cravezic, Naouel Tennoune, Jean-Claude do Rego, Moïse Coëffier, Akio Inui, Pierre Déchelotte, Sergueï O. Fetissov. Increased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia. Frontiers in Nutrition 2016; 3 doi: 10.3389/fnut.2016.00023
|
14 |
Gustav Colldén, Matthias Tschöp, Timo Müller. Therapeutic Potential of Targeting the Ghrelin Pathway. International Journal of Molecular Sciences 2017; 18(4): 798 doi: 10.3390/ijms18040798
|
15 |
Current World Literature. Current Opinion in Supportive & Palliative Care 2009; 3(4): 305 doi: 10.1097/SPC.0b013e3283339c93
|
16 |
R. Northrup, K. Kuroda, E. Manning Duus, S. Routt Barnes, L. Cheatham, T. Wiley, C. Pietra. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model. Supportive Care in Cancer 2013; 21(9): 2409 doi: 10.1007/s00520-013-1800-0
|
17 |
Wei Wu, Lei Zhu, Zhimin Dou, Qiliang Hou, Sen Wang, Ziqian Yuan, Bin Li. Ghrelin in Focus: Dissecting Its Critical Roles in Gastrointestinal Pathologies and Therapies. Current Issues in Molecular Biology 2024; 46(1): 948 doi: 10.3390/cimb46010061
|
18 |
|